Harvard Bioscience execs to present at two virtual investor conferences in May 2026

Harvard Bioscience, Inc. announced that CEO John Duke and CFO Mark Frost will participate in two upcoming virtual investor conferences in May 2026: the Sidoti Micro Cap Conference on May 21 and the Benchmark Healthcare House Call Virtual Conference on May 28. The company will webcast the Sidoti fireside chat live and provide an archived replay afterward. These events offer investors a chance to hear directly from leadership about the company's progress and outlook. Harvard Bioscience is a global developer and seller of life science research technologies, serving academic, pharmaceutical, and biotech clients worldwide.